The Roth lab is based in New York City at Weill Cornell Medical Center and New York Presbyterian Hospital. Our lab studies B-cell lymphomas with a focus on those lymphomas associated with Epstein Bar Virus (EBV) including Hodgkin lymphoma, Burkitt lymphoma, and diffuse large b-cell lymphoma. We study the genomic and epigenomic process that lead to lymphoma and then use this to develop therapies that target those specific vulnerabilities. We are interested in the role that EBV plays in the development of lymphoma and understanding how we can modulate the virus to generate a robust immune response against EBV+ tumors. We are also working to develop novel mouse models of lymphoma to advance our understanding of the disease accelerate the development of novel therapies. Our research is linked to clinical trials which are conducted here at Weill Cornell and as well as nationally and internationally through the Children’s Oncology Group and the NCI clinical trials network.
The important thing in science is not so much to obtain new facts as to discover new ways of thinking about them.
- William Henry Bragg
Our Research
The Roth lab's mission is to optimize immunotherapeutic approaches to EBV-associated lymphomas and investigate the etiology of Hodgkin's lymphoma.
Job Opportunities
Join us in our research! The Roth lab is always looking for highly motivated people to join the lab so check back frequently for job openings.